Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Techno DrugsDHA:TECHNODRUG -2.27%37 Forward Dividend Yield % is 2.11% as of Jul. 24, 2026. GuruFocus rates DHA:TECHNODRUG with a GF Score™ of 37/100. The stock has 10 warning signs investors should review. Among 511 Drug Manufacturers companies, Techno Drugs ranks worse than 50.1% on this metric.
As of today (2026-07-24), the Forward Annual Dividend Yield of Techno Drugs is 2.11%.
As of today (2026-07-24), the Trailing Annual Dividend Yield of Techno Drugs is 2.11%.
DHA:TECHNODRUG's Forward Dividend Yield % is ranked worse than 50.1% of 511
companies
in the Drug Manufacturers industry
Industry Median: 2.07
vs DHA:TECHNODRUG: 2.11
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Techno Drugs Forward Dividend Yield % Related Terms
DHA:TECHNODRUG vs ZTS, UTHR, VTRS: Forward Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Techno Drugs's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Techno Drugs Forward Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Techno Drugs's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Techno Drugs's Forward Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Techno Drugs Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
BDT 1.000000
2025-11-20
2025-11-19
2026-02-10
Cash Dividend
annually
BDT:BDT 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Techno Drugs's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
1
/
47.30
=
2.11 %
Current Share Price is BDT47.30. Techno Drugs's Dividends per Share for the forward twelve months is calculated as BDT1 * 1 = BDT1.
Techno Drugs's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
1
/
47.30
=
2.11 %
Current Share Price is BDT47.30. Techno Drugs's Dividends per Share for the trailing twelve months (TTM) ended in Today is BDT1.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 2.11% mean?
Techno Drugs (DHA:TECHNODRUG) has a Forward Dividend Yield % of 2.11% as of Jul. 24, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Techno Drugs and its competitors. According to the industry distribution chart, Techno Drugs ranks #256 out of 511 companies in the Drug Manufacturers industry, placing it in the top 50.1%.
Is Techno Drugs' Forward Dividend Yield % too high?
Techno Drugs' current Forward Dividend Yield % is 2.11%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.07. Techno Drugs' value of 2.11% is 1.9% above this industry median. Based on the distribution chart, Techno Drugs ranks #256 out of 511 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Techno Drugs has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Techno Drugs' Forward Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Techno Drugs ranks #256 out of 511 companies for Forward Dividend Yield %. This places Techno Drugs in the lower half of its industry. The industry median Forward Dividend Yield % is 2.07. Techno Drugs' value of 2.11% is 1.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.07, based on 511 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Techno Drugs's current Forward Dividend Yield % of 2.11% is 1.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Techno Drugs and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Techno Drugs's current Forward Dividend Yield % is 2.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Techno Drugs stock overvalued right now?
Techno Drugs (DHA:TECHNODRUG) has a current Forward Dividend Yield % of 2.11%. The current Forward Dividend Yield % is 2.11% and 1.9% above the Drug Manufacturers industry median of 2.07. Techno Drugs' overall GF Score™ is 37/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Techno Drugs (DHA:TECHNODRUG), the current Forward Dividend Yield % is 2.11% as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Techno Drugs Ltd is a pharmaceutical company. The company manufactures medicines for the healthcare market with quality products, a distribution channel, and doctor-patient acceptance. The company is also engaged in production of Anti-Cancer medicines and medicines for therapeutic areas like oncology, cardiovascular, diabetes, immune suppressor, anesthetics, life-saving antibiotics & contrast media in Bangladesh. The product portfolio of the company include Algicar Plus, Amoclav Forte, Adesol Oral Solution, Aminovet Injection, Apegestrol Tab, Docetex 20 Inj, and others.
37GF Score
Get the complete analysis for DHA:TECHNODRUG
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:TECHNODRUG has been successfully added to your 
